111 (NASDAQ:YI) Director Jian David Sun Sells 70,440 Shares of Stock

111, Inc. Sponsored ADR (NASDAQ:YI) Director Jian David Sun sold 70,440 shares of 111 stock in a transaction dated Wednesday, May 27th. The shares were sold at an average price of $0.25, for a total transaction of $17,610.00. Following the transaction, the director directly owned 710,551 shares of the company’s stock, valued at approximately $177,637.75. This trade represents a 9.02% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Jian David Sun also recently made the following trade(s):

• On Tuesday, May 26th, Jian David Sun sold 29,280 shares of 111 stock. The shares were sold at an average price of $0.27, for a total transaction of $7,905.60.

111 Price Performance

Shares of NASDAQ YI opened at $5.26 on Friday. 111, Inc. Sponsored ADR has a 1 year low of $2.48 and a 1 year high of $11.17. The stock has a market cap of $46.21 million, a P/E ratio of -5.26 and a beta of 0.66. The firm has a 50-day moving average of $6.26 and a 200 day moving average of $5.58.

Analyst Ratings Changes

Separately, Weiss Ratings raised shares of 111 from a “sell (e+)” rating to a “sell (d-)” rating in a research report on Thursday, May 21st. One analyst has rated the stock with a Sell rating, Based on data from MarketBeat, the company presently has an average rating of “Sell”.

About 111

111, Inc (NASDAQ: YI) is a leading online pharmacy e-commerce platform in China, operating under the brand 111.com. The company provides consumers with a comprehensive selection of pharmaceutical and healthcare products through its proprietary digital channels, including a website and mobile applications. By integrating online ordering, prescription management, and direct-to-consumer delivery, 111, Inc aims to streamline the purchase of medicines and health-related goods for customers nationwide.

111, Inc’s product portfolio encompasses prescription and over-the-counter drugs, nutritional supplements, vitamins, maternal and child care items, personal care products, and beauty goods.